Related Experiment Video

Updated: May 7, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K

The no-reflow phenomenon associated with percutaneous coronary intervention: its mechanisms and treatment

Hiroshi Ito1

  • 1Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, 2-5-1 Kita-ku, Shikata-cho, Okayama, 700-8558, Japan, itomd@md.okayama-u.ac.jp.

Cardiovascular Intervention and Therapeutics
|October 15, 2013
PubMed

Insights

The no-reflow phenomenon in acute coronary syndrome (ACS) impairs blood flow despite artery opening, leading to poor outcomes. Achieving successful myocardial reperfusion is crucial for better functional and clinical results in ACS patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Ischemic Heart Disease

Background:

  • Acute coronary syndrome (ACS) management aims to restore blood flow to the heart muscle.
  • Myocardial ischemia and reperfusion can cause irreversible damage to coronary microvasculatures, leading to the "no-reflow phenomenon."
  • Percutaneous coronary intervention (PCI) can exacerbate microvascular impairment through embolization, attenuating its benefits.

Purpose of the Study:

  • To highlight the clinical significance of the no-reflow phenomenon in ACS.
  • To discuss the impact of microvascular dysfunction on PCI outcomes.
  • To review diagnostic and therapeutic strategies for the no-reflow phenomenon.

Main Methods:

  • Review of current literature on the no-reflow phenomenon in ACS.
  • Analysis of the correlation between no-reflow, infarct size, and clinical outcomes.
  • Discussion of advances in diagnostic imaging and interventional approaches.

Main Results:

  • The no-reflow phenomenon is associated with larger infarct sizes and poorer functional and clinical outcomes in ACS patients.
  • Microvascular dysfunction significantly impacts the effectiveness of PCI.
  • Advances in imaging allow for diagnosis and assessment of microvascular dysfunction.

Conclusions:

  • Successful myocardial reperfusion, not just artery patency, is essential for improved outcomes in ACS.
  • Pharmacological interventions and embolic retrieval devices show promise in managing the no-reflow phenomenon.
  • Addressing microvascular dysfunction is critical for optimizing patient results after ACS events.

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

27.4K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.1K

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
496
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K